On June 29, Pressure Biosciences Inc (OTCMKTS:PBIO) announced its signed agreement with Safer Medical of Montana on production, distribution, commercial roll-out for a novel, effectively water-soluble, nanoemulsified CBD spray for oral use incorporating PBI’s patented Ultra Shear Technology™ (UST™) platform . The plan targets revenues of $3M w/PBI realizing more than $1M.
This morning Pressure BioSciences Inc made a key announcement that may bring the stock into focus and it may be a good idea for investors to take a look into it. The company, which is best known for developing pressure-based instruments that can be deployed in a range of industries, announced that it would be participating in a key event.
The event in question is the Revolutionizing the Development of Plant-Based Food Products webinar that is going to be held on June 30, 2022. It is sponsored by the FORCE Family Office. The webinar is not only going to be available in real-time but it is also going to be interactive in nature and viewers will be able to ask questions.
At the webinar, Pressure BioSciences is going to showcase three of its main tech platform but the primary focus is going to be on its Ultra Shear Technology platform.
The Ultra Shear Technology platform is yet to be launched but it is regarded as revolutionary since it has the capability of processing water and oil into water-soluble and stable nanoemulsions. Such a platform could have a major role to play in the oil and gas industry.
Participation at an event of this nature can also help companies like Pressure BioSciences in getting a larger audience to have a greater idea about the sort of work that they have been doing. In addition to that, it also helps in providing a major platform from which to showcase its products.
